Vir Biotechnology Inc (VIR)
7.38
+0.04
(+0.54%)
USD |
NASDAQ |
Dec 24, 16:00
Vir Biotechnology Cash and Short Term Investments (Quarterly): 914.47M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Janux Therapeutics Inc | 658.03M |
Biomarin Pharmaceutical Inc | 930.44M |
Arbutus Biopharma Corp | 127.79M |
GlycoMimetics Inc | 14.39M |
FibroGen Inc | 131.00M |